{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:47:09Z","timestamp":1788871629017,"version":"build-2803163510"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Drs. K. Najafi"},{"name":"S. Wilmarth"},{"name":"D. Stroman"},{"name":"J. Bartell"},{"name":"W. Gottardi"},{"name":"M. Nagl"},{"name":"NovaBay Pharmaceuticals, Inc."},{"name":"J. Park"},{"name":"Prof. M. Ashby (U. of Oklahoma)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.antiviral.2011.10.009","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T03:22:39Z","timestamp":1318908159000},"page":"470-478","source":"Crossref","is-referenced-by-count":18,"title":["Virucidal mechanism of action of NVC-422, a novel antimicrobial drug for the treatment of adenoviral conjunctivitis"],"prefix":"10.1016","volume":"92","author":[{"given":"Jungjoo","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Jekle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramin","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Ruado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan","family":"Zuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Behzad","family":"Khosrovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahram","family":"Memarzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dmitri","family":"Debabov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.antiviral.2011.10.009_b0005","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004397-200201000-00008","article-title":"A twenty-one year surveillance of adenoviral conjunctivitis in Sapporo, Japan","volume":"42","author":"Aoki","year":"2002","journal-title":"Int. Ophthalmol. Clin."},{"key":"10.1016\/j.antiviral.2011.10.009_b0010","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0021-9673(01)00896-2","article-title":"Polypeptide composition of an adenovirus type 5 used in cancer gene therapy","volume":"921","author":"Blanche","year":"2001","journal-title":"J. Chromatogr. A"},{"issue":"1","key":"10.1016\/j.antiviral.2011.10.009_b0015","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0022-2836(85)90187-1","article-title":"The structure of the adenovirus capsid. II. The packing symmetry of hexon and its implications for viral architecture","volume":"185","author":"Burnett","year":"1985","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2011.10.009_b0020","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1021\/pr025528c","article-title":"Analysis of the adenovirus type 5 proteome by liquid chromatography and tandem mass spectrometry methods","volume":"1","author":"Chelius","year":"2002","journal-title":"J. Proteome Res."},{"issue":"4","key":"10.1016\/j.antiviral.2011.10.009_b0025","doi-asserted-by":"crossref","first-page":"e1000841","DOI":"10.1371\/journal.ppat.1000841","article-title":"Viral capsid is a pathogen-associated molecular pattern in adenovirus keratitis","volume":"6","author":"Chintakuntlawar","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2011.10.009_b0030","series-title":"Human Virology","author":"Collier","year":"2006"},{"issue":"3","key":"10.1016\/j.antiviral.2011.10.009_b0035","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0166-3542(95)00962-0","article-title":"Evaluation of cidofovir (HPMPC, GS-504) against adenovirus type 5 infection in vitro and in a New Zealand rabbit ocular model","volume":"31","author":"de Oliveira","year":"1996","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.antiviral.2011.10.009_b0040","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1006\/viro.1999.0171","article-title":"Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions","volume":"268","author":"Dechecchi","year":"2000","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.antiviral.2011.10.009_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0166-3542(91)90054-U","article-title":"Inhibitory effect of (S)-HPMPC, (S)-HPMPA, and 2\u2019-nor-cyclic GMP on clinical ocular adenoviral isolates is serotype-dependent in vitro","volume":"16","author":"Gordon","year":"1991","journal-title":"Antiviral Res."},{"issue":"9","key":"10.1016\/j.antiviral.2011.10.009_b0055","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/1521-4184(200212)335:9<411::AID-ARDP411>3.0.CO;2-D","article-title":"Chemical properties of N-chlorotaurine sodium, a key compound in the human defence system","volume":"335","author":"Gottardi","year":"2002","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.antiviral.2011.10.009_b0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ardp.200500146","article-title":"N,N-dichlorotaurine: chemical and bactericidal properties","volume":"338","author":"Gottardi","year":"2005","journal-title":"Archiv der Pharmazie: Chemistry in Life Sciences"},{"issue":"5","key":"10.1016\/j.antiviral.2011.10.009_b0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0002-9394(02)01701-4","article-title":"A controlled trial of povidone-iodine to treat infectious conjunctivitis in children","volume":"134","author":"Isenberg","year":"2002","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.antiviral.2011.10.009_b0065","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/jac\/dki057","article-title":"Prospects for adenovirus antivirals","volume":"55","author":"Kinchington","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"issue":"22","key":"10.1016\/j.antiviral.2011.10.009_b0070","doi-asserted-by":"crossref","first-page":"21346","DOI":"10.1074\/jbc.M501170200","article-title":"Taurine chloramine, an oxidant derived from neutrophils, induces apoptosis in human B lymphoma cells through mitochondrial damage","volume":"280","author":"Klamt","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.antiviral.2011.10.009_b0075","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/ncb1968","article-title":"Oxidant-induced apoptosis is mediated by oxidation of the actin-regulatory protein cofilin","volume":"11","author":"Klamt","year":"2009","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.antiviral.2011.10.009_b0080","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0378-4347(99)00316-3","article-title":"Reversed-phase high-performance liquid chromatographic assay for the adenovirus type 5 proteome","volume":"732","author":"Lehmberg","year":"1999","journal-title":"J. Chromatogr. B"},{"issue":"5995","key":"10.1016\/j.antiviral.2011.10.009_b0085","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1126\/science.1187433","article-title":"Atomic structure of human adenovirus by cryo-EM reveals interactions among protein networks","volume":"329","author":"Liu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2011.10.009_b0090","first-page":"597","article-title":"Enhancement of the bactericidal efficacy of N-chlorotaurine by inflammation samples and selected N-H compounds","volume":"21","author":"Nagl","year":"1996","journal-title":"Hygiene and Medizin"},{"issue":"1","key":"10.1016\/j.antiviral.2011.10.009_b0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0166-3542(98)00005-9","article-title":"Activity of N-chlorotaurine against herpes simplex- and adenoviruses","volume":"38","author":"Nagl","year":"1998","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.antiviral.2011.10.009_b0110","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000027477","article-title":"Tolerance of N-chlorotaurine, a new antimicrobial agent, in infectious conjunctivitis \u2013 a phase II pilot study","volume":"214","author":"Nagl","year":"2000","journal-title":"Ophthalmologica"},{"issue":"6","key":"10.1016\/j.antiviral.2011.10.009_b0105","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/jac\/47.6.871","article-title":"Enhanced fungicidal activity of N-chlorotaurine in nasal secretion","volume":"47","author":"Nagl","year":"2001","journal-title":"J. Antimicrob. Chemother."},{"issue":"6","key":"10.1016\/j.antiviral.2011.10.009_b0095","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1128\/AAC.46.6.1996-1999.2002","article-title":"Impact of N-chlorotaurine on viability and production of secreted aspartyl proteinases of Candida spp.","volume":"46","author":"Nagl","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"issue":"2","key":"10.1016\/j.antiviral.2011.10.009_b0115","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jlb.54.2.119","article-title":"Taurine chloramine inhibits the synthesis of nitric oxide and the release of tumor necrosis factor in activated RAW 264.7 cells","volume":"54","author":"Park","year":"1993","journal-title":"J. Leukoc. Biol."},{"issue":"8","key":"10.1016\/j.antiviral.2011.10.009_b0120","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s12325-009-0062-1","article-title":"A combination povidone-iodine 0.4%\/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis","volume":"26","author":"Pelletier","year":"2009","journal-title":"Adv. Ther."},{"issue":"10","key":"10.1016\/j.antiviral.2011.10.009_b0125","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0891-5849(03)00502-1","article-title":"Histamine chloramine reactivity with thiol compounds, ascorbate, and methionine and with intracellular glutathione","volume":"35","author":"Peskin","year":"2003","journal-title":"Free. Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.antiviral.2011.10.009_b0130","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/0006-291X(83)90842-2","article-title":"Effects of culture conditions on glutathione content in A549 cells","volume":"114","author":"Post","year":"1983","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5995","key":"10.1016\/j.antiviral.2011.10.009_b0135","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1126\/science.1187292","article-title":"Crystal structure of human adenovirus at 3.5 A resolution","volume":"329","author":"Reddy","year":"2000","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.antiviral.2011.10.009_b0140","first-page":"460","article-title":"Efficacy of topical cidofovir on multiple adenoviral serotypes in the New Zealand rabbit ocular model","volume":"41","author":"Romanowski","year":"2000","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.antiviral.2011.10.009_b0145","first-page":"1812","article-title":"The antiviral resistance and replication of cidofovir-resistant adenovirus variants in the New Zealand white rabbit ocular model","volume":"42","author":"Romanowski","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"3","key":"10.1016\/j.antiviral.2011.10.009_b0150","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0166-3542(01)00166-8","article-title":"Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5\/New Zealand rabbit ocular model","volume":"52","author":"Romanowski","year":"2001","journal-title":"Antiviral Res."},{"issue":"5","key":"10.1016\/j.antiviral.2011.10.009_b0155","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1167\/iovs.05-1270","article-title":"N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5\/NZW rabbit ocular model","volume":"47","author":"Romanowski","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"10","key":"10.1016\/j.antiviral.2011.10.009_b0160","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1086\/340502","article-title":"Age-related decrease in adenovirus-specific T cell responses","volume":"185","author":"Sester","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"Pt 1","key":"10.1016\/j.antiviral.2011.10.009_b0165","first-page":"25","article-title":"Adenovirus structure by X-ray crystallography and electron microscopy","volume":"199","author":"Stewart","year":"1995","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"7","key":"10.1016\/j.antiviral.2011.10.009_b0170","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1002\/j.1460-2075.1993.tb05919.x","article-title":"Difference imaging of adenovirus: bridging the resolution gap between X-ray crystallography and electron microscopy","volume":"12","author":"Stewart","year":"1993","journal-title":"The EMBO J."},{"issue":"4","key":"10.1016\/j.antiviral.2011.10.009_b0175","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1172\/JCI111544","article-title":"Generation of nitrogen-chlorine oxidants by human phagocytes","volume":"74","author":"Test","year":"1984","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.antiviral.2011.10.009_b0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/jop.2005.21.157","article-title":"Tolerability and efficacy of N-chlorotaurine in epidemic keratoconjunctivitis \u2013 a double-blind, randomized, phase-2 clinical trial","volume":"21","author":"Teuchner","year":"2005","journal-title":"J. Ocul. Pharmacol. Ther."},{"issue":"12","key":"10.1016\/j.antiviral.2011.10.009_b0185","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1007\/s00417-008-0900-x","article-title":"Tolerability of N-chlorotaurine plus ammonium chloride in the rabbit and human eye \u2013 a phase 1 clinical study","volume":"246","author":"Teuchner","year":"2008","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.antiviral.2011.10.009_b0190","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0076-6879(86)32042-1","article-title":"Preparation and characterization of chloramines","volume":"132","author":"Thomas","year":"1986","journal-title":"Methods Enzymol."},{"issue":"7","key":"10.1016\/j.antiviral.2011.10.009_b0195","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","article-title":"HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses","volume":"94","author":"Tomko","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.antiviral.2011.10.009_b0205","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/bjo.84.9.968","article-title":"Clinical and epidemiological features of acute follicular conjunctivitis with special reference to that caused by herpes simplex virus type 1","volume":"84","author":"Uchio","year":"2000","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.antiviral.2011.10.009_b0200","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2147\/OPTH.S14282","article-title":"Antiadenoviral effects of N-chlorotaurine in vitro confirmed by quantitative polymerase chain reaction methods","volume":"4","author":"Uchio","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"10.1016\/j.antiviral.2011.10.009_b0215","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/j.tetlet.2008.02.038","article-title":"N-Chloro-2,2-dimethyltaurines: a new class of remarkably stable N-chlorotaurines","volume":"49","author":"Wang","year":"2008","journal-title":"Tetrahedron Lett."},{"issue":"6","key":"10.1016\/j.antiviral.2011.10.009_b0210","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1128\/AAC.00158-11","article-title":"Chemical characterization and biological properties of NVC-422, a novel, stable N-chlorotaurine","volume":"55","author":"Wang","year":"2011","journal-title":"Analog. Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.antiviral.2011.10.009_b0220","first-page":"173","article-title":"Acute hemorrhagic conjunctivitis","volume":"45","author":"Wright","year":"1992","journal-title":"Am. Fam. Physician"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211004591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354211004591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T17:51:02Z","timestamp":1560793862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354211004591"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0166354211004591"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2011.10.009","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}